Erratum to "Effects of the use of growth hormone in children, adolescents with juvenile idiopathic arthritis: a systematic review"(Rev Bras Reumatol. 2017;57(2):100-106)

Similar Items

• Síndrome da encefalopatia posterior reversível (PRES) e lúpus eritematoso sistêmico: relato de dois casos [Rev Bras Reumatol 2012; 52(5):804-10] Posterior reversible encephalopathy syndrome (PRES) and systemic lupus erythematosus: report of two cases [Rev Bras Reumatol 2012; 52(5):804-10]
  by: A de S Streck, et al.
  Published: (2013-02-01)
• Anticorpos anti-C1q, anticromatina/nucleossomo e anti-dsDNA em pacientes com lúpus eritematoso sistêmico juvenil [Rev Bras Reumatol 2012; 52(6):971-81] Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients [Rev Bras Reumatol 2012; 52(6):971-81]
  by: AA Jesus, et al.
  Published: (2013-02-01)
• Effects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review
  by: Renan Bazuco Frittoli, et al.
• Nota de preocupação: Ahlin E et al., "Anticorpos antipeptídeos citrulinados e fator reumatoide em pacientes sudaneses com infecção por Leishmania donovani", Rev Bras Reumatol 2011; 51(6):572-86 Expression of concern: Ahlin E et al.,"Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection", Rev Bras Reumatol 2011; 51(6):572-86
  by: Paulo Louzada-Junior, et al.
  Published: (2012-10-01)
• Rev Bras Hematol Hemoter. 2012;34(2)
  Published: (2012-01-01)